Navigation Links
Cardium Announces Follow-On Direct Investment by Institutional Investor
Date:6/30/2008

SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) announced that it has completed a registered direct offering with an institutional investor that participated in its prior financing for the purchase of shares of its common stock and warrants to purchase additional shares of common stock. The transaction resulted in gross proceeds to Cardium of approximately $3.25 million, before placement agent fees and offering expenses and excluding any future proceeds from the exercise of the warrants issued in the offering. Empire Asset Management Company acted as financial advisor and the sole placement agent for the transaction.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The securities were offered pursuant to an effective shelf registration statement filed by Cardium with the U.S. Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy, and these securities may not be sold in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications. Cardium's lead product candidate, Generx(TM) (alferminogene tadenovec, Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential use by interventio
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cardium Selected for Inclusion in Russell Microcap Index
2. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
3. Cardium Launches New AWARE Clinical Study Website
4. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
5. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
6. Cardium Reports on First Quarter 2008 Highlights and Financial Results
7. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
8. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
9. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
10. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
11. Cardium Completes $5.3 Million Registered Direct Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...he Ninth Circuit Court of Appeals reversed a U.S. ...allowed to pursue all of its claims against The La...urt for trial. CTI filed a complaint against The ... consultant for CTI,s product TRISENOX, in 2007 se...
(Date:11/19/2009)...Newswire/ -- Danish Prince Joachim inaugurated the...in Kalundborg, Denmark, on Wednesday, November 18....est 2nd generation ethanol demonstration biorefine...he plant,s innovative process for converting straw... first to market with commercial enzymes for conve...
(Date:11/19/2009)...ewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: N...ng letter to its shareholders, discussing the Comp...iopharmaceuticals Holdings, Inc. (CHBP), an integr...e,s Republic of China. The merger gives NeoStem a ...ical Co. Ltd., CHBP,s primary operating subsidiary...
(Date:11/19/2009)...ewswire/ - Aegera Therapeutics Inc. announced toda...Phase 2B study of AEG35156, a targeted antisense t...ncology indications. ,, The study, entitled "An...ed Inhibitor of Apoptosis (XIAP) Antisense AEG3515...nd Idarubicin in AML Following Failure of a Single...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...ETA, Calif., April 9 Copan Diagnostics, Inc. is p...: Walk-Away Specimen Processor in Canada at Vancou...cimen Processor is a revolutionary system for auto... The breakthrough technology behind the WASP, coup...ab system for automation, make the WASP the first ...
...EIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biote...nd provider of vaccines in China, today announced,...three and twelve month,periods ended December 31, ... -- Record full year 2008 sales increasing 39% y...6.93 million doses of Healive(R) in 2008, up from ...
...O, Calif., April 9 BioMarin Pharmaceutical Inc. (... Bienaime, Chief Executive Officer of BioMarin, wi... April 30, at 5:00 p.m. ET (23:00 CET) to discuss ...S. / Canada Dial-in Number: 866.383.7998, Inte...ipant Code: 63957862, Replay Dial-in Number: 88...
Other Biology Technology:Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 13Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 14Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 15Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 16Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 17Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 18BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET) 2
(Date:11/23/2009)...ble in German . , Of all global carbon diox...mosphere where it contributes to global warming. T...ial ecosystems such as forests, grasslands and pea...c and terrestrial ecosystems is considered one of ...limate change. However, new greenhouse gas bookkee...
(Date:11/22/2009)...ne deletion can increase the likelihood of immune ...n, an international team of researchers reports in...enetics . When the gene, called UGT2B17, is missin...ient,s, transplants have a significantly greater r...-host disease, in which immune cells from the dono...
(Date:11/21/2009)...ember 20,2009 / b3c newswire / - KINAXO Biotechn...ing round, gaining two new investors in the compan...AXO reports that Jrgen Schumacher has been elected..., KINAXO shareholders Axel Ullrich, Hellmut Kirch...utional investors Mountain Partners, BioM, High-Te...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 1Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 2Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 1Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 2Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 3Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 4Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 5Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 1Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 5
...who ate fish at least once a week displayed higher...it ate it less frequently, according to a study of...ue of Acta Paediatrica . , Eating fish once a ...isuospatial intelligence scores by an average of s...ek increased them by just under 11 per cent. , Sw...
...ets of human DNA put scientists from the Universit... chromosome 8 occurs with significantly higher fr...n the control group. The results are to be publish... Genetics . , Cleft lips and palates are among th... 700 babies in Central Europe are affected. Childr...
...rsity of California, San Diego, offer a new explan... in of mammals found along the Malay Peninsula in ...ecies in the absence of any geographical barrier.... and the Andaman Sea was once thought have split t...s of animals to diverge. But a recent revision of ...
Other Biology News:Teenage boys who eat fish at least once a week achieve higher intelligence scores 2Teenage boys who eat fish at least once a week achieve higher intelligence scores 3Cleft lip and palate: Genes more important than thought? 2New explanation for a puzzling biological divide along the Malay Peninsula 2
Eco RII (Bst NI) from Roche Applied Science
...pe I eukaryotic topoisomerase that removes both po...d right- and left-handed supercoils) from covalent...valently closed, circular DNA with fewer positive ...I does not absolutely require Mg 2+ to function, ...
...ivity Kit TNF-α Converting Enzyme Activity K...AW CYCLES. The InnoZyme™ TACE Activity Kit i...re human TACE activity in cell lysates and biologi...n Anti-Human TACE-Coated 96-Well Plate is pre-coat...
...ains reagents required to perform a bisulfite modi...n, all unmethylated cytosines are deaminated and s...hylcytosines remain unaltered. Thus, the sequence ...r the DNA is originally methylated or unmethylated...
Biology Products: